498 related articles for article (PubMed ID: 32842818)
1. Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2.
Fadaka AO; Sibuyi NRS; Adewale OB; Bakare OO; Akanbi MO; Klein A; Madiehe AM; Meyer M
J Int Med Res; 2020 Aug; 48(8):300060520949077. PubMed ID: 32842818
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
3. Where are we with understanding of COVID-19?
Akula SM; McCubrey JA
Adv Biol Regul; 2020 Aug; 77():100745. PubMed ID: 32773101
[TBL] [Abstract][Full Text] [Related]
4. Understanding of COVID-19 based on current evidence.
Sun P; Lu X; Xu C; Sun W; Pan B
J Med Virol; 2020 Jun; 92(6):548-551. PubMed ID: 32096567
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19.
Abd Ellah NH; Gad SF; Muhammad K; E Batiha G; Hetta HF
Nanomedicine (Lond); 2020 Sep; 15(21):2085-2102. PubMed ID: 32723142
[TBL] [Abstract][Full Text] [Related]
6. Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.
Li H; Liu Z; Ge J
J Cell Mol Med; 2020 Jun; 24(12):6558-6570. PubMed ID: 32320516
[TBL] [Abstract][Full Text] [Related]
7. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
Giovane RA; Rezai S; Cleland E; Henderson CE
Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
[TBL] [Abstract][Full Text] [Related]
8. The Wuhan SARS-CoV-2-What's next for China.
Lu H; Stratton CW; Tang YW
J Med Virol; 2020 Jun; 92(6):546-547. PubMed ID: 32115732
[No Abstract] [Full Text] [Related]
9. Treatment of SARS-CoV-2: How far have we reached?
Ahsan W; Javed S; Bratty MA; Alhazmi HA; Najmi A
Drug Discov Ther; 2020 May; 14(2):67-72. PubMed ID: 32336723
[TBL] [Abstract][Full Text] [Related]
10. COVID-2019: update on epidemiology, disease spread and management.
Sahu KK; Mishra AK; Lal A
Monaldi Arch Chest Dis; 2020 Apr; 90(1):. PubMed ID: 32297723
[TBL] [Abstract][Full Text] [Related]
11. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
12. India's Battle against COVID-19: Progress and Challenges.
Laxminarayan R; Jameel S; Sarkar S
Am J Trop Med Hyg; 2020 Oct; 103(4):1343-1347. PubMed ID: 32840205
[No Abstract] [Full Text] [Related]
13. COVID-19: Transmission, prevention, and potential therapeutic opportunities.
Lotfi M; Hamblin MR; Rezaei N
Clin Chim Acta; 2020 Sep; 508():254-266. PubMed ID: 32474009
[TBL] [Abstract][Full Text] [Related]
14. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
Gupta SP
Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 pandemic: An overview.
Acuti Martellucci C; Flacco ME; Cappadona R; Bravi F; Mantovani L; Manzoli L
Adv Biol Regul; 2020 Aug; 77():100736. PubMed ID: 32773099
[TBL] [Abstract][Full Text] [Related]
16. An overview of COVID-19.
Shi Y; Wang G; Cai XP; Deng JW; Zheng L; Zhu HH; Zheng M; Yang B; Chen Z
J Zhejiang Univ Sci B; 2020 May; 21(5):343-360. PubMed ID: 32425000
[TBL] [Abstract][Full Text] [Related]
17. Drug repositioning is an alternative for the treatment of coronavirus COVID-19.
Serafin MB; Bottega A; Foletto VS; da Rosa TF; Hörner A; Hörner R
Int J Antimicrob Agents; 2020 Jun; 55(6):105969. PubMed ID: 32278811
[TBL] [Abstract][Full Text] [Related]
18. Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.
Jogalekar MP; Veerabathini A; Gangadaran P
Exp Biol Med (Maywood); 2020 Jun; 245(11):964-969. PubMed ID: 32306751
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
Banerjee AK; Arora N
Curr Top Med Chem; 2020; 20(16):1434-1437. PubMed ID: 32282303
[No Abstract] [Full Text] [Related]
20. Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.
Kouzy R; Abi Jaoude J; Garcia Garcia CJ; El Alam MB; Taniguchi CM; Ludmir EB
JAMA Netw Open; 2020 Jul; 3(7):e2015100. PubMed ID: 32658285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
